Objective:

To compile published data reporting fatal, severe, or long-term complications impacting the biliary system post-COVID-19 infection, specifically focusing on the definition of long-COVID.

Approach:

Key Findings:

• 23 studies met inclusion criteria after screening 38,148 titles and abstracts, involving a total of X patients.
• Hepatobiliary disorders included post-COVID-19 cholangitis, cholecystitis, and hepatitis, affecting Y, Z, and W patients respectively.
• COVID-19 has emerged as a significant contributor to both acute and chronic liver injuries.

Interpretation:

The findings indicate a notable prevalence of severe hepatobiliary complications following COVID-19, suggesting the need for ongoing monitoring and management of liver health in recovered patients to improve clinical outcomes.

Limitations:

• Exclusion of non-English studies may limit generalizability and introduce language bias.
• Potential biases in study selection and data extraction processes.

Conclusion:

The study highlights the importance of recognizing and addressing hepatobiliary disorders as significant long-term complications of COVID-19.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.